108 related articles for article (PubMed ID: 17425199)
21. Negative Predictive Value and Significance of Benign-Appearing Endometrial Cells in Papanicolaou Tests.
Yu J; Onisko A; Austin RM
Am J Clin Pathol; 2017 Sep; 148(3):274-279. PubMed ID: 28821196
[TBL] [Abstract][Full Text] [Related]
22. Correlation between endometrial cells on Papanicolaou smear and endometrial carcinoma.
Kerpsack JT; Finan MA; Kline RC
South Med J; 1998 Aug; 91(8):749-52. PubMed ID: 9715221
[TBL] [Abstract][Full Text] [Related]
23. Significance of benign endometrial cells in Pap smears from postmenopausal women.
Wu HH; Schuetz MJ; Cramer H
J Reprod Med; 2001 Sep; 46(9):795-8. PubMed ID: 11584479
[TBL] [Abstract][Full Text] [Related]
24. Endometrial cells on Pap tests: ideal reporting is more complex than just finding the right age.
Fischer G; Haddad M; Cormier K
Diagn Cytopathol; 2017 Jul; 45(7):587-591. PubMed ID: 28421714
[TBL] [Abstract][Full Text] [Related]
25. Value of histiocyte detection in Pap smears for predicting endometrial pathology. An institutional experience.
Nassar A; Fleisher SR; Nasuti JF
Acta Cytol; 2003; 47(5):762-7. PubMed ID: 14526675
[TBL] [Abstract][Full Text] [Related]
26. Normal endometrial cells in cervical cytology: systematic review of prevalence and relation to significant endometrial pathology.
Canfell K; Kang YJ; Clements M; Moa AM; Beral V
J Med Screen; 2008; 15(4):188-98. PubMed ID: 19106259
[TBL] [Abstract][Full Text] [Related]
27. In Papanicolaou smears, benign appearing endometrial cells bear no significance in predicting uterine endometrial adenocarcinomas.
Moatamed NA; Le LT; Levin MR; Govind R; Apple SK
Diagn Cytopathol; 2013 Apr; 41(4):335-41. PubMed ID: 22102567
[TBL] [Abstract][Full Text] [Related]
28. Change of Practice Patterns Following an Educational Comment on Reports of Benign-Appearing Endometrial Cells in Papanicolaou Tests.
Jones TE; Onisko A; Austin RM; Yu J
Am J Clin Pathol; 2022 Mar; 157(3):413-416. PubMed ID: 34528660
[TBL] [Abstract][Full Text] [Related]
29. Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System.
Bean SM; Connolly K; Roberson J; Eltoum I; Chhieng DC
Cancer; 2006 Feb; 108(1):39-44. PubMed ID: 16329117
[TBL] [Abstract][Full Text] [Related]
30. Value of cervical cytology in diagnosing endometrial carcinoma in women with postmenopausal bleeding.
van Doom HC; Opmeer BC; Kooi GS; Ewing-Graham PC; Kruitwagen RF; Mol BW
Acta Cytol; 2009; 53(3):277-82. PubMed ID: 19534267
[TBL] [Abstract][Full Text] [Related]
31. The Clinical Significance of Endometrial Cells Detected on Pap Testing: The Impact of Revisions to the 3rd Edition of the Bethesda System for Reporting Cervical Cytology.
Morikawa LH; Tauchi-Nishi PS
Ann Clin Lab Sci; 2017 May; 47(3):298-305. PubMed ID: 28667030
[TBL] [Abstract][Full Text] [Related]
32. Reporting normal endometrial cells in Pap smears: an outcome appraisal.
Gomez-Fernandez CR; Ganjei-Azar P; Capote-Dishaw J; Averette HE; Nadji M
Gynecol Oncol; 1999 Sep; 74(3):381-4. PubMed ID: 10479497
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of a cytologic diagnosis of atypical glandular cells, favor endometrial origin, in Pap smears.
Saad RS; Takei H; Liu YL; Silverman JE; Lipscomb JT; Ruiz B
Acta Cytol; 2006; 50(1):48-54. PubMed ID: 16514840
[TBL] [Abstract][Full Text] [Related]
34. Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles.
Baker VL; Draper M; Paul S; Allerheiligen S; Glant M; Shifren J; Jaffe RB
J Clin Endocrinol Metab; 1998 Jan; 83(1):6-13. PubMed ID: 9435408
[TBL] [Abstract][Full Text] [Related]
35. Normal endometrial cells in liquid-based cervical cytology specimens in women aged 40 or older.
Moroney JW; Zahn CM; Heaton RB; Crothers B; Kendall BS; Elkas JC
Gynecol Oncol; 2007 Jun; 105(3):672-6. PubMed ID: 17363044
[TBL] [Abstract][Full Text] [Related]
36. Normal endometrial cells in Papanicolaou smears: prevalence in women with and without endometrial disease.
Zucker PK; Kasdon EJ
Obstet Gynecol; 2001 May; 97(5 Pt 1):798-9. PubMed ID: 11354070
[No Abstract] [Full Text] [Related]
37. Quantification of apoptotic phenomenon on endometrial biopsies in postmenopausal patients under hormonal replacement therapy (HRT).
Terzea D; Iosif C; Vasilescu F; Andrei F; Dobrea C; Nicolae A; Georgescu A; Mircea F; Ceauşu M; Vişan A; Mihai M; Ardeleanu C
Rom J Morphol Embryol; 2007; 48(2):107-11. PubMed ID: 17641796
[TBL] [Abstract][Full Text] [Related]
38. Rebleeding and endometrial growth in women with postmenopausal bleeding and endometrial thickness < 5 mm managed by dilatation and curettage or ultrasound follow-up: a randomized controlled study.
Epstein E; Valentin L
Ultrasound Obstet Gynecol; 2001 Nov; 18(5):499-504. PubMed ID: 11844172
[TBL] [Abstract][Full Text] [Related]
39. Significance of "normal" endometrial cells in cervical cytology from asymptomatic postmenopausal women receiving hormone replacement therapy.
Montz FJ
Gynecol Oncol; 2001 Apr; 81(1):33-9. PubMed ID: 11277646
[TBL] [Abstract][Full Text] [Related]
40. The effects of the Bethesda System 2014 on endometrial cell reporting and follow-up endometrial biopsies in women 45 years of age and over.
Moyer AB; El-Zaatari ZM; Thrall MJ
J Am Soc Cytopathol; 2018; 7(4):201-204. PubMed ID: 31043277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
